Emergent BioSolutions (NYSE:EBS) Raised to Buy at StockNews.com
Emergent BioSolutions (NYSE:EBS – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. Other analysts have also recently issued reports about the stock. HC Wainwright restated a “buy” rating and set a $15.00 price objective on shares of Emergent […]
